ESR1 c.453-15634G>A

Variant ID: 6-152148098-G-A

NM_000125.3(ESR1):c.453-15634G>A

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Elía, Andrés A; Saldain, Leo L; Vanzulli, Silvia I SI; Helguero, Luisa A LA; Lamb, Caroline A CA; Fabris, Victoria V; Pataccini, Gabriela G; Martínez-Vazquez, Paula P; Burruchaga, Javier J; Caillet-Bois, Ines I; Spengler, Eunice E; Acosta Haab, Gabriela G; Liguori, Marcos M; Castets, Alejandra A; Lovisi, Silvia S; Abascal, María F MF; Novaro, Virginia V; Sánchez, Jana J; Muñoz, Javier J; Belizán, Jose M JM; Abba, Martín C MC; Gass, Hugo H; Rojas, Paola P; Lanari, Claudia C
Publication Date: 2022-10-21

Variant appearance in text: ESR1: 453-15634G>A; rs7753153
PubMed Link: 36269797
Variant Present in the following documents:
  • ccr-22-2060_supplementary_table_s5_suppts5.xlsx, sheet 1
View BVdb publication page



Association of variants in estrogen-related pathway genes with prostate cancer risk.

The Prostate
Holt, Sarah K SK; Kwon, Erika M EM; Fu, Rong R; Kolb, Suzanne S; Feng, Ziding Z; Ostrander, Elaine A EA; Stanford, Janet L JL
Publication Date: 2013-01

Variant appearance in text: rs7753153
PubMed Link: 22549291
Variant Present in the following documents:
  • Main text
View BVdb publication page